aTTP

Sanofi promises money back for discontinued blood disorder treatment – in some cases
Endpoints
Mon, 01/23/23 - 10:00 pm
Sanofi
drug warranty programs
Cablivi
aTTP
FDA approves Sanofi's Cablivi for rare clotting disease
BioCentury
Wed, 02/6/19 - 03:27 pm
Sanofi
Cablivi
aTTP
FDA
Sanofi reaps first fruit of Ablynx buyout with a European OK for its lead rare disease drug
Endpoints
Tue, 09/4/18 - 05:01 pm
Ablynx
Sanofi
Europe
caplacizumab
M&A
aTTP
Sanofi’s rare disease drug Cablivi approved in the EU
Pharmaforum
Mon, 09/3/18 - 12:17 pm
Sanofi
Europe
Cablivi
aTTP
Ablynx files rare blood disorder drug, raising prospect of first commercial product next year
Fierce Biotech
Tue, 02/7/17 - 10:32 am
Ablynx
caplacizumab
Europe
aTTP